低剖面覆膜支架治疗急性复杂型B型主动脉夹层的1年结果
前瞻性关键试验评估RelayPro覆膜支架治疗急性复杂型B型主动脉夹层,涉及美国22个中心、56例患者,30天全因死亡率为1.8%,技术成功率为100%,主要不良事件发生率为10.7%,结论认为RelayPro安全有效,随访仍在进行以评估长期结局。
要点
- 30天全因死亡率为1.8%(1/56;95%CI上限8.2%;P<.0001)。
- 技术成功率为100%,大多数手术为经皮(85.5%)。
- 6例患者发生7例主要不良事件(10.7%),包括截瘫3例、轻瘫2例、致残性卒中1例、肾衰竭1例。
核心结论
- RelayPro在急性复杂型B型主动脉夹层中安全有效,随访仍在进行以评估长期结局和耐久性。
研究设计与样本
- 前瞻性关键试验,分析30天全因死亡率主要终点,次要终点评估至5年。
- 研究涉及美国22个中心,2017年至2021年入组56例患者(平均年龄59.5±11.4岁),其中73.2%为男性,53.6%为非裔美国人。
主要发现
- 30天全因死亡率为1.8%(1/56;95%CI上限8.2%;P<.0001)。
- 技术成功率为100%,中位住院时间为7天(四分位距5-12天)。
- 6例患者发生7例主要不良事件(10.7%),包括截瘫3例、轻瘫2例、致残性卒中1例和肾衰竭1例;所有截瘫/轻瘫经腰椎引流后缓解。
- Kaplan-Meier分析估计30天至3年各时间点无主要不良事件生存率为89.1%。
- 发生1例内漏(Ia型)、2例逆行性夹层、2例主动脉直径增长;无破裂、瘘、组件分离、通畅性丧失、狭窄、扭结、扭转、鸟嘴、装置完整性丧失或断裂。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The safety and effectiveness of the RelayPro endograft (Terumo Aortic) was assessed for the treatment of acute, complicated type B aortic dissection (TBAD). METHODS: A prospective pivotal trial analyzed a primary end point of all-cause mortality at 30 days. Secondary end points included technical success, major adverse events (disabling stroke, renal failure, and paraplegia/paralysis), endoleaks, patency, rupture, device integrity, false lumen perfusion, reinterventions, aortic expansion, and migration evaluated to 5 years. RESULTS: The study involved 22 United States centers and enrolled 56 patients (mean age, 59.5 ± 11.4 years) from 2017 to 2021; of whom, 73.2% were men and 53.6% were African American. TBAD was complicated by malperfusion of the kidneys (51.8%), lower extremities (35.7%), and viscera (33.9%), and rupture (10.7%). Dissection extended proximally to zones 1/2 (14.3%) and zone 3 (78.6%) and distally to the iliac arteries (67.3%). Most procedures were percutaneous (85.5%). Technical success was 100%. Median hospitalization was 7 days (interquartile range, 5-12 days). All-cause mortality at 30 days was 1.8% (1 of 56; upper 95% CI, 8.2%; P < .0001). Seven major adverse events occurred in 6 patients (10.7%), consisting of paraplegia (n = 3), paraparesis (n = 2), disabling stroke (n = 1), and renal failure (n = 1). All paraplegia/paraparesis resolved with lumbar drainage. Kaplan-Meier analysis estimated a freedom from major adverse events of 89.1% at each interval from 30 days to 3 years. There was 1 endoleak (Type Ia), 2 retrograde dissections, and aortic diameter growth occurred in 2. There has been no rupture, fistula, component separation, patency loss, stenosis, kinking, twisting, bird beak, loss of device integrity, or fracture. CONCLUSIONS: RelayPro is safe and effective in acute, complicated TBAD. Follow-up is ongoing to evaluate longer-term outcomes and durability.
引用
- Rossi PJ, Desai ND, Malaisrie SC, et al. One-Year Results of a Low-Profile Endograft in Acute, Complicated Type B Aortic Dissection. Ann Thorac Surg. 2023. PMID: 37769702. doi:10.1016/j.athoracsur.2023.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。